Fresenius SE & Co KGaA ADR (FSNUY PINK) stock market data APIs
$12.0793
0.21(1.7%)
as of May 8, 2025
Fresenius SE & Co KGaA ADR Financial Data Overview
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Prev. Close
12.0793
Open
12.2877
High
12.1525
Low
12.0548
52 wk Range
7.47-12.44
Market Cap
27 261 M
P/E Ratio
26.8889
Shares Outstanding
2 253 M
Revenue
21 833 M
EPS
0.1136
Beta
0.956
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Fresenius SE & Co KGaA ADR data using free add-ons & libraries
Get Fresenius SE & Co KGaA ADR Fundamental Data
Fresenius SE & Co KGaA ADR Fundamental data includes:
- Net Revenue: 21 833 M
- EBITDA: 2 588 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-26
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Fresenius SE & Co KGaA ADR News
New
Fresenius SE & Co KGaA (FSNUF) Q1 2025 Earnings Call Highlights: Strong EPS Growth and ...
EPS Growth: Double-digit growth, with core EPS up 12% in Q1. Kabi EBIT Margin: Increased to 16.8%. Organic Revenue Growth: 7% for the group. EBIT Growth: 4% at constant currency. Group EBIT Margin: 11...
Fresenius: Q1 Earnings Snapshot
BAD HOMBURG, Germany (AP) — BAD HOMBURG, Germany (AP) — Fresenius Medical Care AG (FMS) on Tuesday reported first-quarter profit of $158.8 million. On a per-share basis, the Bad Homburg, Germany-...
Stocks to watch next week: Berkshire Hathaway, Palantir, TSMC, Novo Nordisk and JD Wetherspoon
The coming week is expected to be another busy one for earnings releases, with a number of major companies due to report. As tariff uncertainty continues to loom over markets, investors will be keepi...
Retail investors who hold 37% of Fresenius SE & Co. KGaA (ETR:FRE) gained 5.9%, institutions profited as well
Key Insights Significant control over Fresenius SE KGaA by retail investors implies that the general public has more power to influence management and governance-related decisions A total of 16 inves...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
